Enhance Skin Products Inc (EHSK)

Not featured in screeners

Not featured in screeners

Ticker: EHSK

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Botnevik Frode

1 purchase — total 9,973 USD

Buy 22 Jul 2013

Value US$4,281,496.69 | Price 352.30 | Shares 23,290

Biostrategies Consulting Group Inc

2 sales — total 99,917 USD

Sale 12 May 2010

Value US$2,867,101.41 | Price 444.83 | Shares 67,132

Sale 12 May 2010

Value US$267,859.37 | Price 200.51 | Shares 80,130

Asculai Samuel

CEO

1 buy, 1 sell — total 99,917 USD

Buy 12 May 2010

Value US$8,250.00 | Price 0.01 | Shares 825,000

Sale 12 May 2010

Value US$91,666.66 | Price 0.01 | Shares 9,166,666

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2013-07-24	2013-07-22	B Purchase	Botnevik Frode Non-Executive Director	23,290 +16.5% 352.30 US$4,281,497	23,290 +16.5%	352.30	US$4,281,497
2010-08-19	2010-05-12	S Sale	Biostrategies Consulting Group Inc Large shareholder	67,132 +15.5% 444.83 US$2,867,101	67,132 +15.5%	444.83	US$2,867,101
2010-08-19	2010-05-12	B Purchase	Asculai Samuel CEO Executive Director Large shareholder	28,830 +18.4% 224.83 US$2,961,167	28,830 +18.4%	224.83	US$2,961,167
2010-08-19	2010-05-12	S Sale	Biostrategies Consulting Group Inc Large shareholder	9,166,666 -33.3% 0.01 US$91,667	9,166,666 -33.3%	0.01	US$91,667
2010-08-19	2010-05-12	S Sale	Asculai Samuel CEO Executive Director Large shareholder	9,166,666 -34.4% 0.01 US$91,667	9,166,666 -34.4%	0.01	US$91,667

More insider trading research around Enhance Skin Products Inc